Riverbend Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.64M Sell
18,202
-2,075
-10% -$287K 1.2% 21
2026
Q2
$2.61M Buy
20,277
+1,596
+9% +$187K 1.31% 17
2026
Q1
$2.25M Buy
18,681
+1,413
+8% +$163K 1.29% 18
2025
Q4
$1.82M Buy
17,268
+2,072
+14% +$195K 1.13% 24
2025
Q3
$1.28M Buy
15,196
+740
+5% +$61K 0.89% 31
2025
Q2
$1.14M Buy
14,456
+963
+7% +$76.5K 0.87% 34
2025
Q1
$1.21M Buy
13,493
+6,178
+84% +$577K 1.08% 24
2024
Q4
$729K Buy
+7,315
New +$754K 0.65% 43

Other funds holding MRK

Riverbend Wealth Management's MRK Position: Q3 2026 in Review

Riverbend Wealth Management reduced its Merck (MRK) stake by 10% in Q3 2026, selling an estimated $287K and leaving 18,202 shares worth $2.64M. The position accounts for 1.2% of the portfolio, ranked #21.

Riverbend Wealth Management first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Riverbend Wealth Management held 18,202 shares of Merck worth $2.64M as of Q3 2026.
  • Riverbend Wealth Management sold 2,075 Merck shares in Q3 2026, an estimated $287K.
  • Merck made up 1.2% of Riverbend Wealth Management's portfolio in Q3 2026, its #21 holding.
  • Riverbend Wealth Management first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Riverbend Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.